rs7198799
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004360.5(CDH1):c.164-17183C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.269 in 151,868 control chromosomes in the GnomAD database, including 5,635 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.27   (  5635   hom.,  cov: 31) 
Consequence
 CDH1
NM_004360.5 intron
NM_004360.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.0870  
Publications
16 publications found 
Genes affected
 CDH1  (HGNC:1748):  (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015] 
CDH1 Gene-Disease associations (from GenCC):
- blepharocheilodontic syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), G2P
- CDH1-related diffuse gastric and lobular breast cancer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- hereditary diffuse gastric adenocarcinomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- cleft soft palateInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- orofacial cleft 3Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- blepharocheilodontic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.286  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CDH1 | NM_004360.5 | c.164-17183C>T | intron_variant | Intron 2 of 15 | ENST00000261769.10 | NP_004351.1 | ||
| CDH1 | NM_001317184.2 | c.164-17183C>T | intron_variant | Intron 2 of 14 | NP_001304113.1 | |||
| CDH1 | NM_001317185.2 | c.-1452-17183C>T | intron_variant | Intron 2 of 15 | NP_001304114.1 | |||
| CDH1 | NM_001317186.2 | c.-1656-17183C>T | intron_variant | Intron 2 of 14 | NP_001304115.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.270  AC: 40900AN: 151750Hom.:  5639  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
40900
AN: 
151750
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.269  AC: 40907AN: 151868Hom.:  5635  Cov.: 31 AF XY:  0.268  AC XY: 19880AN XY: 74222 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
40907
AN: 
151868
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
19880
AN XY: 
74222
show subpopulations 
African (AFR) 
 AF: 
AC: 
10314
AN: 
41430
American (AMR) 
 AF: 
AC: 
3784
AN: 
15240
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1371
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
1070
AN: 
5148
South Asian (SAS) 
 AF: 
AC: 
1228
AN: 
4804
European-Finnish (FIN) 
 AF: 
AC: 
2540
AN: 
10572
Middle Eastern (MID) 
 AF: 
AC: 
96
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
19632
AN: 
67902
Other (OTH) 
 AF: 
AC: 
587
AN: 
2102
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1502 
 3004 
 4506 
 6008 
 7510 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 426 
 852 
 1278 
 1704 
 2130 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
937
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.